JPIAMR Network for Integrating Microbial Sequencing and Platforms for Antimicrobial Resistance (Seq4AMR)



Research Network: 2020-11-01 - 2022-10-31
Total sum awarded: €79 710

Main Questions/Approach: How can we best identify and promote collaboration and implementation between AMR NGS stakeholders that link the individual fields of (new) NGS technologies, algorithms, quality standards, teaching/training and sequence databanks? Answer - By establishing an international and interdisciplinary OneHealth network of public and private experts to take the lead in identifying potential knowledge gaps and solutions. Further, by developing AMR NGS-dedicated quality and teaching/training materials. Finally, by promoting discussion and interactions between AMR NGS stakeholders and other working groups with cross-cutting priorities - including extensive use of JPIAMR VRI. Objectives: 1) Promote active collaboration between interdisciplinary OneHealth AMR NGS stakeholders 2) Identify knowledge gaps and provide solutions to current/future AMR NGS issues 3) Formulate recommendations on quality and quality materials 4) Educate AMR NGS stakeholders via interdisciplinary-directed AMR NGS teaching/training materialsActivities: 1) Dedicated website and access to network materials 2) Face-to-face network meetings and regular teleconferences (in collaboration with other relevant JPIAMR working groups) 3) Open access publications and collation of a Seq4AMR Strategic Roadmap 4) Dedicated interdisciplinary Seq4AMR webinar(s) and course(s) 5) Dedicated Seq4AMR workshop at a relevant international meeting 6) Promotion of Seq4AMR and JPIAMR during conferences.Expected Results: 1) Establish new OneHealth AMR synergies between international and interdisciplinary experts for knowledge exchange, joint publications grant writing etc. 2) Identify current knowledge gaps and how to best fill these gaps 3) Formulate quality recommendations and access to materials 4) Develop new interdisciplinary AMR teaching/training/ materials 5) To publish a Seq4AMR Strategic Roadmap 6) To contribute and strengthen the activities of JPIAMR VRI

Read More
Read Less
  • John Hays, Erasmus MC University Medical Center, Netherlands (Coordinator)
  • Stefan Emler, SmartGene GmbH, Switzerland (Observer)
  • Eric Claas, Leiden University, Netherlands (Observer)
  • Andreas Posch, Ares Genetics GmbH, Austria (Observer)
  • Richard Stabler, Liverpool School of Tropical Medicine, United Kingdom (Observer)
  • Aitana Lebrand, SIB Swiss Institute of Bioinformatics, Switzerland (Observer)
  • Andrew Stubbs, Erasmus MC University Medical Center, Netherlands (Observer)
  • Willem van Leeuwen, University of Applied Sciences Leiden, Netherlands (Observer)
  • Liping Ma, East China Normal University, China (Observer)
  • Willy Valdivia, Orion Integrated Biosciences Inc., USA (Observer)
  • Alex van Belkum, BioMérieux, France (Observer)
  • Eric Kristiansson, Chalmers University of Technology, Sweden (Partner)
  • Sebastian Bruchmann, University of Cambridge, United Kingdom (Observer)
  • Andrew McArthur, McMaster University, Canada (Observer)
  • A. Heikema, Erasmus MC University Medical Center, Netherlands (Observer)
  • Stephan Beisken, Ares Genetics GmbH, Austria (Observer)
  • M. Petrillo, Joint Research Centre (JRC), Italy (Observer)
  • S. Capella-Gutierrez, Barcelona Supercomputing Centre (BSC), Spain (Observer)
  • L. Portell, Barcelona Supercomputing Centre (BSC), Spain (Observer)
  • B. Grüning, Freiburg Galaxy Team, Germany (Observer)
  • G. Cuccuru, Freiburg Galaxy Team, Germany (Observer)
  • C. Carrillo, Canadian Food Inspection Agency, Canada (Observer)
  • B. Blais, Canadian Food Inspection Agency, Canada (Observer)
  • B. Gruening, University of Freiburg, Germany (Observer)
  • W. Meier, University of Freiburg, Germany (Observer)
  • B. Batut, University of Freiburg, Germany (Observer)
  • K. Vanneste, Sciensano, Belgium (Observer)
  • Johan Bengtsson-Palme, University of Gothenburg, Sweden (Observer)
  • Thierry Naas, Hopital de Bicêtre, France (Observer)
  • N. Strepis, Erasmus MC University Medical Center, Netherlands (Observer)
  • A. Rhod Larsen, Statens Serum Institute, Denmark (Observer)
  • B. Helwigh, Technical University of Denmark, Denmark (Observer)
  • H. Hasman, Technical University of Denmark, Denmark (Observer)
  • R. Hendriksen, Technical University of Denmark, Denmark (Observer)
  • Sofia Forslund, Max Delbrück Center for Molecular Medicine, Germany (Observer)
  • L. Pedro Coelho, Institute of Science and Technology, Fudan University, Shanghai,, China (Observer)
  • A. Patak, Molecular Biology and Genomics Unit, Institute for Health and Consumer Protection, Italy (Observer)
  • M. Querci, Joint Research Centre European Commission, Brussels,, Belgium (Observer)
  • G. van den Eede, Health, Consumer and Reference Materials, European Union, Belgium (Observer)